about
Predicting a positive response to intravenous immunoglobulin in isolated lower motor neuron syndromes.Identifying the pattern of olfactory deficits in Parkinson disease using the brief smell identification test.An inflammatory review of Parkinson's disease.A Temporal Association between Accumulated Petrol (Gasoline) Lead Emissions and Motor Neuron Disease in Australia.VISA--a pass to innate immunity.Identification and outcomes of clinical phenotypes in amyotrophic lateral sclerosis/motor neuron disease: Australian National Motor Neuron Disease observational cohort.Involvement of quinolinic acid in the neuropathogenesis of amyotrophic lateral sclerosis.Predictive genetic testing for amyotrophic lateral sclerosis and frontotemporal dementia: genetic counselling considerations.Increased peripheral inflammation in asymptomatic leucine-rich repeat kinase 2 mutation carriers.SNCA Gene, but Not MAPT, Influences Onset Age of Parkinson's Disease in Chinese and Australians.Differential effects of human neuromelanin and synthetic dopamine melanin on neuronal and glial cells.Motor neuron disease mortality and lifetime petrol lead exposure: Evidence from national age-specific and state-level age-standardized death rates in Australia.Novel TBK1 truncating mutation in a familial amyotrophic lateral sclerosis patient of Chinese origin.Effects of cerebrospinal fluid from patients with Parkinson disease on dopaminergic cells.Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis.Cross-ethnic meta-analysis identifies association of the GPX3-TNIP1 locus with amyotrophic lateral sclerosis.Inhibitor treatment of peripheral mononuclear cells from Parkinson's disease patients further validates LRRK2 dephosphorylation as a pharmacodynamic biomarker.Corticomotoneuronal function in asymptomatic SOD-1 mutation carriers.Isolated fascicular oculomotor nerve palsy as the initial presentation of the antiphospholipid syndrome.A functional polymorphism in the parkin gene promoter affects the age of onset of Parkinson's disease.Do polymorphisms in the familial Parkinsonism genes contribute to risk for sporadic Parkinson's disease?A possible role for humoral immunity in the pathogenesis of Parkinson's disease.Haplotype analysis of the IGF2-INS-TH gene cluster in Parkinson's disease.Interleukin-12 and interferon-gamma are not detectable in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis.Genetic and Pathological Assessment of hnRNPA1, hnRNPA2/B1, and hnRNPA3 in Familial and Sporadic Amyotrophic Lateral Sclerosis.Interaction between α-synuclein and tau genotypes and the progression of Parkinson's disease.Measurement of LRRK2 and Ser910/935 phosphorylated LRRK2 in peripheral blood mononuclear cells from idiopathic Parkinson's disease patients.Adult-onset Alexander's disease mimicking degenerative disease.Novel prion protein gene mutation presenting with subacute PSP-like syndrome.The genotype-phenotype landscape of familial amyotrophic lateral sclerosis in Australia.Nocturnal hypoxia in motor neuron disease is not predicted by standard respiratory function tests.Prevalence and clinical features of common LRRK2 mutations in Australians with Parkinson's disease.Antibodies from patients with Parkinson's disease react with protein modified by dopamine oxidation.Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in miceReduced T helper and B lymphocytes in Parkinson's diseaseMitochondrial DNA haplogroups J and K are not protective for Parkinson's disease in the Australian communityAnticipation of onset age in familial Parkinson's disease without SCA gene mutationsGenetic contributions to Parkinson's diseaseLimitations of Electromyography in the Assessment of Abdominal Wall Muscle Contractility Following Botulinum Toxin A InjectionMonozygotic twins and triplets discordant for amyotrophic lateral sclerosis display differential methylation and gene expression.
P50
Q34069679-20D506EA-EDB5-42EC-8C9F-8D4861E08CB9Q34191963-2E668845-E7FA-485E-931C-526147CED9A7Q35046915-E8290501-5D3A-4794-BEEE-147C46428028Q36403811-C3A56FB1-2449-47EB-B012-F2C16B1CBEE7Q36618404-C72E2F31-7963-4958-B3AB-0FE6267853F5Q37312624-90A2604C-A457-4AA9-9799-0910FCC2E620Q38856007-714F4E65-18D0-4DD7-97C8-931C33F7AC16Q39354046-B295A3B5-E106-4FAA-A829-3CA8B34C3416Q39967268-378D49FB-B7C9-4B7D-98A3-4ACB7E57E3E8Q40047619-86344EF5-1A48-4F05-970D-FBB76219EEEEQ40379280-8B861C63-6CDD-4E16-8EEA-37546A334C6AQ40417987-5CF1BC06-B6A1-41AF-9DE9-4E1099952023Q40561697-8C3AB259-EFCD-4EF4-911E-FF587E2EE85DQ40972156-6AAE094A-CE4E-4528-A3C1-12F35536AD98Q41392222-2AEBBD64-26F6-4237-AEAE-2ED77B96E56CQ41701081-4663860D-84CA-492C-B13A-F5F3E986B42FQ42372493-97B22E47-7A34-44A4-8116-830342926F81Q43110796-AA2DDBA5-CB6E-492A-B38D-14F2D342BB1AQ44327048-B5882928-8BBA-4E56-A617-DCFDC2B66B0EQ45182630-F32BA18C-3831-45AD-8187-B474B7185F2CQ46118551-A8AB3C8B-B96C-44F2-A04F-4548239E3641Q46748023-86872AA2-01BE-479D-8436-2AACBDFF8265Q46846353-000A4B78-8FBB-4A25-871D-2C15EC507B4EQ47326476-F7976020-3C62-4A7F-B8FF-86B2372A69CBQ47409917-0118CC93-0D48-4C67-84A4-4E91B898D57AQ47794314-EC114FFD-97FE-4136-93D3-88363C5CDB17Q47795467-386645AB-7CA3-4DBE-9283-955FE6BFA7FFQ48154679-F398FE67-72C2-4CE9-BF68-C0C4E6BBEB4DQ48246405-3FEE298F-FE77-45F1-92C8-8924938D5FDAQ48331920-3A40BB05-BA20-4218-900F-F3959B59825EQ48497041-81469576-70FB-4DBC-AECC-EBC57CCB2A6BQ50276912-B4948286-A495-4448-94B0-91B3A6766EE1Q54165493-F8BB76D6-CFAB-42E6-B04F-0D9675C19B33Q58091986-95F33F2B-5AA4-4DC6-A221-E11F54B0D209Q59544583-BD17FFD1-C833-45B2-A414-60D28D7B59DAQ59544602-E58A2E6E-6642-4B51-91FE-20F51C7A298CQ59544625-FD989D36-C95B-4E87-B27E-8A14D268B834Q59544643-4E37B922-E116-42CE-9C8E-700C6459ABF2Q64063757-3C230E8D-86FD-4111-A9C6-A887AFC9AFCFQ64917154-7282735E-E696-4555-B709-78BA386F15E0
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Dominic B Rowe
@ast
Dominic B Rowe
@en
Dominic B Rowe
@es
Dominic B Rowe
@nl
Dominic B Rowe
@sl
type
label
Dominic B Rowe
@ast
Dominic B Rowe
@en
Dominic B Rowe
@es
Dominic B Rowe
@nl
Dominic B Rowe
@sl
prefLabel
Dominic B Rowe
@ast
Dominic B Rowe
@en
Dominic B Rowe
@es
Dominic B Rowe
@nl
Dominic B Rowe
@sl
P1053
B-6661-2011
P106
P1153
7201668122
P31
P496
0000-0003-0912-2146